<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33839588</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-3064</ISSN><JournalIssue CitedMedium="Internet"><Volume>181</Volume><PubDate><Year>2021</Year><Month>May</Month></PubDate></JournalIssue><Title>Respiratory medicine</Title><ISOAbbreviation>Respir Med</ISOAbbreviation></Journal><ArticleTitle>Integrative respiratory follow-up of severe COVID-19 reveals common functional and lung imaging sequelae.</ArticleTitle><Pagination><StartPage>106383</StartPage><MedlinePgn>106383</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.rmed.2021.106383</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0954-6111(21)00089-5</ELocationID><Abstract><AbstractText Label="BACKGROUND">COVID-19 pandemic resulted in an unprecedented number of hospitalizations in general wards and intensive care units (ICU). Severe and critical COVID-19 patients suffer from extensive pneumonia; therefore, long-term respiratory sequelae may be expected.</AbstractText><AbstractText Label="RESEARCH QUESTION">We conducted a cohort study to determine respiratory sequelae in patients with severe and critical COVID-19. We aimed at evaluating the proportion of patients with persisting respiratory symptoms and/or abnormalities in pulmonary function tests (PFT) or in lung imaging.</AbstractText><AbstractText Label="STUDY DESIGN">and methods: This is a single center cohort study including COVID-19 survivors who underwent a three-month follow-up with clinical evaluation, PFT and lung high-resolution computed tomography (HRCT). All clinical, functional, and radiological data were centrally reviewed. Multiple linear regression analysis was performed to identify factors associated with residual lesions on HRCT.</AbstractText><AbstractText Label="RESULTS">Full clinical evaluation, PFT and lung HRCT were available for central review in 126, 122 and 107 patients, respectively. At follow-up, 25% of patients complained from dyspnea and 35% from fatigue, lung diffusion capacity (DLCO) was decreased in 45%, 17% had HRCT abnormalities affecting more than 5% of their lung parenchyma while signs of fibrosis were found in 21%. In multiple linear regression model, number of days in ICU were related to the extent of persisting lesions on HRCT, while intubation was associated with signs of fibrosis at follow-up (P&#xa0;=&#xa0;0.0005, Fisher's exact test). In contrast, the severity of lung imaging or PFT changes were not predictive of fatigue and dyspnea.</AbstractText><AbstractText Label="INTERPRETATION">Although most hospitalized COVID-19 patients recover, a substantial proportion complains from persisting dyspnea and fatigue. Impairment of DLCO and signs suggestive of fibrosis are common but are not strictly related to long-lasting symptoms.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Froidure</LastName><ForeName>Antoine</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pulmonology Department, Cliniques Universitaires Saint-Luc, Universit&#xe9; Catholique de Louvain, Bruxelles, Belgium; Institut de Recherche Exp&#xe9;rimentale et Clinique (IREC), Universit&#xe9; Catholique de Louvain, Belgium. Electronic address: antoine.froidure@uclouvain.be.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahsouli</LastName><ForeName>Amin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Radiology Department, Cliniques Universitaires Saint-Luc, Universit&#xe9; Catholique de Louvain, Bruxelles, Belgium; Institut de Recherche Exp&#xe9;rimentale et Clinique (IREC), Universit&#xe9; Catholique de Louvain, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liistro</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Pulmonology Department, Cliniques Universitaires Saint-Luc, Universit&#xe9; Catholique de Louvain, Bruxelles, Belgium; Institut de Recherche Exp&#xe9;rimentale et Clinique (IREC), Universit&#xe9; Catholique de Louvain, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Greef</LastName><ForeName>Julien</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>General Internal Medicine and Infectious Disease Department, Cliniques Universitaires Saint-Luc, Universit&#xe9; Catholique de Louvain, Bruxelles, Belgium; Institut de Recherche Exp&#xe9;rimentale et Clinique (IREC), Universit&#xe9; Catholique de Louvain, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belkhir</LastName><ForeName>Leila</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>General Internal Medicine and Infectious Disease Department, Cliniques Universitaires Saint-Luc, Universit&#xe9; Catholique de Louvain, Bruxelles, Belgium; Institut de Recherche Exp&#xe9;rimentale et Clinique (IREC), Universit&#xe9; Catholique de Louvain, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xe9;rard</LastName><ForeName>Ludovic</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Intensive Care Department, Cliniques Universitaires Saint-Luc, Universit&#xe9; Catholique de Louvain, Bruxelles, Belgium; Institut de Recherche Exp&#xe9;rimentale et Clinique (IREC), Universit&#xe9; Catholique de Louvain, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertrand</LastName><ForeName>Aur&#xe9;lie</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Support en M&#xe9;thodologie et Calcul Statistique (SMCS), Universit&#xe9; Catholique de Louvain, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koenig</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Pulmonology Department, Cliniques Universitaires Saint-Luc, Universit&#xe9; Catholique de Louvain, Bruxelles, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pothen</LastName><ForeName>Lucie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>General Internal Medicine and Infectious Disease Department, Cliniques Universitaires Saint-Luc, Universit&#xe9; Catholique de Louvain, Bruxelles, Belgium; Institut de Recherche Exp&#xe9;rimentale et Clinique (IREC), Universit&#xe9; Catholique de Louvain, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yildiz</LastName><ForeName>Halil</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>General Internal Medicine and Infectious Disease Department, Cliniques Universitaires Saint-Luc, Universit&#xe9; Catholique de Louvain, Bruxelles, Belgium; Institut de Recherche Exp&#xe9;rimentale et Clinique (IREC), Universit&#xe9; Catholique de Louvain, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mwenge</LastName><ForeName>Benny</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Pulmonology Department, Cliniques Universitaires Saint-Luc, Universit&#xe9; Catholique de Louvain, Bruxelles, Belgium; Institut de Recherche Exp&#xe9;rimentale et Clinique (IREC), Universit&#xe9; Catholique de Louvain, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aboubakar</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Pulmonology Department, Cliniques Universitaires Saint-Luc, Universit&#xe9; Catholique de Louvain, Bruxelles, Belgium; Institut de Recherche Exp&#xe9;rimentale et Clinique (IREC), Universit&#xe9; Catholique de Louvain, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gohy</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Pulmonology Department, Cliniques Universitaires Saint-Luc, Universit&#xe9; Catholique de Louvain, Bruxelles, Belgium; Institut de Recherche Exp&#xe9;rimentale et Clinique (IREC), Universit&#xe9; Catholique de Louvain, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pilette</LastName><ForeName>Charles</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Pulmonology Department, Cliniques Universitaires Saint-Luc, Universit&#xe9; Catholique de Louvain, Bruxelles, Belgium; Institut de Recherche Exp&#xe9;rimentale et Clinique (IREC), Universit&#xe9; Catholique de Louvain, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reychler</LastName><ForeName>Gregory</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Pulmonology Department, Cliniques Universitaires Saint-Luc, Universit&#xe9; Catholique de Louvain, Bruxelles, Belgium; Institut de Recherche Exp&#xe9;rimentale et Clinique (IREC), Universit&#xe9; Catholique de Louvain, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coche</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Radiology Department, Cliniques Universitaires Saint-Luc, Universit&#xe9; Catholique de Louvain, Bruxelles, Belgium; Institut de Recherche Exp&#xe9;rimentale et Clinique (IREC), Universit&#xe9; Catholique de Louvain, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yombi</LastName><ForeName>Jean-Cyr</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>General Internal Medicine and Infectious Disease Department, Cliniques Universitaires Saint-Luc, Universit&#xe9; Catholique de Louvain, Bruxelles, Belgium; Institut de Recherche Exp&#xe9;rimentale et Clinique (IREC), Universit&#xe9; Catholique de Louvain, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghaye</LastName><ForeName>Benoit</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Radiology Department, Cliniques Universitaires Saint-Luc, Universit&#xe9; Catholique de Louvain, Bruxelles, Belgium; Institut de Recherche Exp&#xe9;rimentale et Clinique (IREC), Universit&#xe9; Catholique de Louvain, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Respir Med</MedlineTA><NlmUniqueID>8908438</NlmUniqueID><ISSNLinking>0954-6111</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016014" MajorTopicYN="N">Linear Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049268" MajorTopicYN="N">Positron-Emission Tomography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011856" MajorTopicYN="N">Radiographic Image Enhancement</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012129" MajorTopicYN="N">Respiratory Function Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID19</Keyword><Keyword MajorTopicYN="N">Follow-up</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Lung HRCT</Keyword><Keyword MajorTopicYN="N">Lung fibrosis</Keyword><Keyword MajorTopicYN="N">Pulmonary function tests</Keyword></KeywordList><CoiStatement>The authors have no conflict of interest in relationship with the present work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>11</Day><Hour>20</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>4</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33839588</ArticleId><ArticleId IdType="pmc">PMC8019490</ArticleId><ArticleId IdType="doi">10.1016/j.rmed.2021.106383</ArticleId><ArticleId IdType="pii">S0954-6111(21)00089-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tyrrell C.S.B., Mytton O.T., Gentry S.V., Thomas-Meyer M., Allen J.L.Y., Narula A.A., et al. Managing intensive care admissions when there are not enough beds during the COVID-19 pandemic: a systematic review. Thorax. 2021;76:302&#x2013;312.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7892390</ArticleId><ArticleId IdType="pubmed">33334908</ArticleId></ArticleIdList></Reference><Reference><Citation>Kontis V., Bennett J.E., Rashid T., Parks R.M., Pearson-Stuttard J., Guillot M., et al. Magnitude, demographics and dynamics of the effect of the first wave of the COVID-19 pandemic on all-cause mortality in 21 industrialized countries. Nat. Med. 2020;26(12):1919&#x2013;1928.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7615092</ArticleId><ArticleId IdType="pubmed">33057181</ArticleId></ArticleIdList></Reference><Reference><Citation>Salimi S., Hamlyn J.M. COVID-19 and crosstalk with the hallmarks of aging. J. Gerontol. A Biol. Sci. Med. Sci. 2020;75(9):e34&#x2013;e41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7337690</ArticleId><ArticleId IdType="pubmed">32544216</ArticleId></ArticleIdList></Reference><Reference><Citation>Docherty A.B., Harrison E.M., Green C.A., Hardwick H.E., Pius R., Norman L., et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369:m1985.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7243036</ArticleId><ArticleId IdType="pubmed">32444460</ArticleId></ArticleIdList></Reference><Reference><Citation>Verity R., Okell L.C., Dorigatti I., Winskill P., Whittaker C., Imai N., et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect. Dis. 2020;20(6):669&#x2013;677.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7158570</ArticleId><ArticleId IdType="pubmed">32240634</ArticleId></ArticleIdList></Reference><Reference><Citation>Piroth L., Cottenet J., Mariet A.S., Bonniaud P., Blot M., Tubert-Bitter P., et al. Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study. Lancet Respir. Med. 2020;9(3):251&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832247</ArticleId><ArticleId IdType="pubmed">33341155</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenthal N., Cao Z., Gundrum J., Sianis J., Safo S. Risk factors associated with in-hospital mortality in a US national sample of patients with COVID-19. JAMA Netw. Open. 2020;3(12)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7729428</ArticleId><ArticleId IdType="pubmed">33301018</ArticleId></ArticleIdList></Reference><Reference><Citation>Nurchis M.C., Pascucci D., Sapienza M., Villani L., D'Ambrosio F., Castrini F., et al. Impact of the burden of COVID-19 in Italy: results of disability-adjusted life years (DALYs) and productivity loss. Int. J. Environ. Res. Publ. Health. 2020;17(12)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7345321</ArticleId><ArticleId IdType="pubmed">32545827</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Wu J., Hao S., Yang M., Lu X., Chen X., et al. Long term outcomes in survivors of epidemic Influenza A (H7N9) virus infection. Sci. Rep. 2017;7(1):17275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5722861</ArticleId><ArticleId IdType="pubmed">29222500</ArticleId></ArticleIdList></Reference><Reference><Citation>Das K.M., Lee E.Y., Singh R., Enani M.A., Al Dossari K., Van Gorkom K., et al. Follow-up chest radiographic findings in patients with MERS-CoV after recovery. Indian J. Radiol. Imag. 2017;27(3):342&#x2013;349.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5644332</ArticleId><ArticleId IdType="pubmed">29089687</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogliani P., Calzetta L., Coppola A., Puxeddu E., Sergiacomi G., D'Amato D., et al. Are there pulmonary sequelae in patients recovering from COVID-19? Respir. Res. 2020;21(1):286.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7598236</ArticleId><ArticleId IdType="pubmed">33126869</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y.M., Shang Y.M., Song W.B., Li Q.Q., Xie H., Xu Q.F., et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020;25:100463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference><Reference><Citation>Quanjer P.H., Stanojevic S., Cole T.J., Baur X., Hall G.L., Culver B.H., et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur. Respir. J. 2012;40(6):1324&#x2013;1343.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3786581</ArticleId><ArticleId IdType="pubmed">22743675</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanojevic S., Graham B.L., Cooper B.G., Thompson B.R., Carter K.W., Francis R.W., et al. Official ERS technical standards: global Lung Function Initiative reference values for the carbon monoxide transfer factor for Caucasians. Eur. Respir. J. 2017;50(3)</Citation><ArticleIdList><ArticleId IdType="pubmed">28893868</ArticleId></ArticleIdList></Reference><Reference><Citation>Homayounieh F., Rockenbach MA Bezerra Cavalcanti, Ebrahimian S., Doda Khera R., Bizzo B.C., Buch V., et al. Multicenter assessment of CT pneumonia analysis prototype for predicting disease severity and patient outcome. J. Digit. Imag. 2021:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7906242</ArticleId><ArticleId IdType="pubmed">33634416</ArticleId></ArticleIdList></Reference><Reference><Citation>Froidure A., Mahieu M., Hoton D., Laterre P.F., Yombi J.C., Koenig S., et al. Short telomeres increase the risk of severe COVID-19. Aging (Albany NY) 2020;12(20):19911&#x2013;19922.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7655194</ArticleId><ArticleId IdType="pubmed">33104521</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Borst B., Peters J.B., Brink M., Schoon Y., Bleeker-Rovers C.P., Schers H., et al. Comprehensive health assessment three months after recovery from acute COVID-19. Clin. Infect. Dis. 2020 ciaa1750.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7717214</ArticleId><ArticleId IdType="pubmed">33220049</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde M.W., Kim S.S., Lindsell C.J., Billig Rose E., Shapiro N.I., Files D.C., et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network - United States, March-June 2020. MMWR Morb. Mortal. Wkly. Rep. 2020;69(30):993&#x2013;998.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M., Braillard O., Alcoba G., Aebischer Perone S., Courvoisier D., Chappuis F., et al. COVID-19 symptoms: longitudinal evolution and persistence in outpatient settings. Ann. Intern. Med. 2020 M20-5926.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7741180</ArticleId><ArticleId IdType="pubmed">33284676</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T., Sahanic S., Pizzini A., Luger A., Schwabl C., Sonnweber B., et al. Cardiopulmonary recovery after COVID-19 - an observational prospective multi-center trial. Eur. Respir. J. 2020;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7736754</ArticleId><ArticleId IdType="pubmed">33303539</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera-Benitez N.E., Laffey J.G., Parotto M., Spieth P.M., Villar J., Zhang H., et al. Mechanical ventilation-associated lung fibrosis in acute respiratory distress syndrome: a significant contributor to poor outcome. Anesthesiology. 2014;121(1):189&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4991945</ArticleId><ArticleId IdType="pubmed">24732023</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F., Lagares D., Choi K.M., Stopfer L., Marinkovic A., Vrbanac V., et al. Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis. Am. J. Physiol. Lung Cell Mol. Physiol. 2015;308(4):L344&#x2013;L357.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4329470</ArticleId><ArticleId IdType="pubmed">25502501</ArticleId></ArticleIdList></Reference><Reference><Citation>Botta M., Tsonas A.M., Pillay J., Boers L.S., Algera A.G., Bos L.D.J., et al. Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID): a national, multicentre, observational cohort study. Lancet Respir. Med. 2020;9(2):139&#x2013;148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7584441</ArticleId><ArticleId IdType="pubmed">33169671</ArticleId></ArticleIdList></Reference><Reference><Citation>Flaherty K.R., Wells A.U., Cottin V., Devaraj A., Walsh S.L.F., Inoue Y., et al. Nintedanib in progressive fibrosing interstitial lung diseases. N. Engl. J. Med. 2019;381(18):1718&#x2013;1727.</Citation><ArticleIdList><ArticleId IdType="pubmed">31566307</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>